Roger L Whiting

Title: The Innovative Contributions of Roger L. Whiting

Introduction

Roger L. Whiting is a distinguished inventor based in Los Altos, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuronal damage and the development of novel compounds. With a total of 13 patents to his name, Whiting's work has had a profound impact on medical science.

Latest Patents

Among his latest patents are methods for the treatment of neuronal damage associated with ischemia. He has also developed benzocycloalkylazolethione derivatives and processes for preparing these compounds. The present invention relates to novel benzocycloalkylazolethione compounds that act as dopamine β-hydroxylase inhibitors. These compounds feature a benzocycloalkyl portion selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl, and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl, with various possible substitutions. The azolethione portion includes options such as 2-thioxo-2,3-dihydro-1H-imidazol-3-yl and 5-thioxo-4,5-dihydro-1H-1,2,4-triazol-4-yl, among others. His patents also cover prodrugs, pharmaceutically acceptable salts, individual isomers, and mixtures of isomers, along with methods for using and preparing these compounds.

Career Highlights

Whiting has had a notable career, working with reputable organizations such as Syntex Pharmaceuticals, Ltd. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in drug development and treatment methodologies.

Collaborations

Throughout his career, Roger L. Whiting has collaborated with esteemed colleagues, including Brian J. Alps and Jean C. Pascal. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Roger L. Whiting's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the treatment of neuronal damage and the development of new therapeutic compounds.